Pharmachem Acquires Improve USA
Improve USA is a leading manufacturer of aloe vera liquid and powder.
Pharmachem Laboratories Inc. (Kearny, NJ) has acquired aloe vera manufacturer Improve USA (DeSoto, TX). Improve USA owns three aloe vera manufacturing facilities in Mexico and is a vertically integrated supplier.
“The facilities are fully integrated from farming operations that grow the aloe vera, to the production facilities that convert the leaves to powder or liquid forms for use in a variety of customer applications,” says Improve USA president Peter Hafermann. “We’re in control of the entire production process which translates into improved quality and production capabilities for our customers in support of the multi-billion dollar consumer market for aloe vera-containing products.”
Pharmachem says that Improve USA will retain its current management and employees while becoming a Pharmachem subsidiary.
Mars partners with suppliers like ADM to bring regeneratively grown ingredients to pet food
November 25th 2024Mars (Franklin, TN) is collaborating with partners and suppliers like ADM, The Anderson, Inc., Riceland Foods, and Soil and Water Outcomes Fund through its Royal Canin USA and Petcare U.S. Inc. brands to provide financial incentives to farmers to implement regenerative agricultural practices.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
